d'Onofrio F, Cologno D, Petretta V, Casucci G, Bussone G
Institute of Neurology, San G. Moscati Hospital, Avellino, Italy.
Neurol Sci. 2007 May;28 Suppl 2:S239-41. doi: 10.1007/s10072-007-0787-z.
Basilar-type migraine (BM) has been recognised in the revised International Classification of Headache Disorders as a distinct clinical entity (subtype of migraine with aura), characterised by disturbing migraine aura clearly originating from the brainstem or from both hemispheres simultaneously affected. It differs from familial and sporadic hemiplegic migraines by the absence of motor deficit. Lamotrigine has been shown to be effective in preventing migraine aura symptoms in typical aura and in some cases of BM. We tried lamotrigine in three female cases of BM.
基底型偏头痛（BM）在修订后的《国际头痛疾病分类》中被确认为一种独特的临床实体（有先兆偏头痛的亚型），其特征为明显起源于脑干或同时累及双侧半球的令人不安的偏头痛先兆。它与家族性和散发性偏瘫性偏头痛的区别在于没有运动功能缺损。拉莫三嗪已被证明在预防典型先兆偏头痛和某些基底型偏头痛病例的偏头痛先兆症状方面有效。我们对3例基底型偏头痛女性患者试用了拉莫三嗪。
